Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy clinical trials

Explore recruiting patients with her2 positive locally advanced inoperable or metastatic breast cancer with disease controlled after 2 years of maintenance treatment with anti her2 targeted therapy clinical trials.

Also recruiting in Europe

Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HEROES: De-escalation of medical therapies in HER2-positive metastatic breast cancer in long-term persistent response and minimal residual disease undetectable in circulating tumor DNA

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy trials by city

Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Toronto Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Vancouver Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Montreal Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Calgary Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Edmonton Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Ottawa Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Winnipeg Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Quebec City Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Hamilton Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Kitchener Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in London Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Halifax Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in New York Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Los Angeles Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Chicago Patients With Her2 Positive Locally Advanced Inoperable Or Metastatic Breast Cancer With Disease Controlled After 2 Years Of Maintenance Treatment With Anti Her2 Targeted Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease